Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go:
16
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go:
Expired
investment:
£220,780
Hitmarker is a proprietary job platform that covers the entire video game sector. It aims to be the leading job provider in the $159 billion video game industry. It has a database of 67,000 candidates and has posted 46,000 jobs from 4,500 companies in 77 countries. The company asserts that one million people have used Hitmarker 2.5 million times to post or look for jobs. Hitmarker has been covered by publications like Forbes, CNBC, and The FT. It has also onboarded 20 partners, including The University of California, RGF Executive Search, and the British Esports Association. The company will use the investment to build a global network of localised platforms in crucial territories and expand its addressable market.
days to go:
Expired
investment:
£521,283
Established in 2011, Crowdcube has become the market leader in the equity crowdfunding sector. The company has a 40% share of the UK market with over 620,000 investors registered on the platform that have invested more than £561m in pitches. This has resulted in nearly 800 successful campaigns and Crowdcube's revenue increasing by 33% from H1 2017 to H1 2018. Funds are being raised to scale the business by expanding further in the UK, as well as overseas.
days to go:
Expired
investment:
£7,918,180
YoungPlanet enables parents to put their children's unused things to use with new families and away from landfills for free via its app. The company cites PwC data estimating the UK’s sharing economy to be worth £9 billion by 2025. It aims to be a contender in this segment. The company argues further that 10-year-olds in the UK will own on average 238 toys at any one time and yet play with just 12. This leads to UK households wasting over 25 million tonnes a year, with one-fourth of this number ending up in landfills as per the Department for Environment, Food and Rural Affairs (DEFRA). YoungPlanet aims to change this. It has onboarded 36,000 users on its platform to date and featured in press publications such as BBC News, Vanessa Feltz, and LadBible. YoungPlanet will use the investment to scale nationally, begin generating first phase revenue via brand sponsorship of events, branded gamification, and Business-to-Business (B2B) subscriptions for semi-closed communities via its app.
days to go:
Expired
investment:
£547,103
